Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

Overview of attention for article published in Targeted Oncology, June 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 155 Dimensions

Readers on

mendeley: 116 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 13,250 followers.

New publication: Ph1b trial of anti-CCL2 in solid tumors with multiple drug combos. http://t.co/IblweRmjfN http://t.co/bbcz4R7mhF

Reply Repost Favourite

New publication: Ph1b trial of anti-CCL2 in solid tumors with multiple drug combos. http://t.co/IblweRmjfN http://t.co/bbcz4R7mhF

Reply Repost Favourite

Ph1b highlights: Taught to block a tumor chemokine: CCL2 Octopus design: multi-arm drug combos accelerate recruitment http://t.co/IblweRmjfN

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.